The Intersect ENT Inc (XENT) Cut to “Market Perform” at Northland Securities

The Intersect ENT Inc (XENT) Cut to “Market Perform” at Northland Securities

A number of other equities analysts have also recently issued reports on the company. William Blair restated an outperform rating on shares of Intersect ENT in a report on Wednesday, May 10th. Canaccord Genuity restated a buy rating on shares of Intersect ENT in a report on Wednesday, May 3rd. Zacks Investment Research upgraded Intersect ENT from a strong sell rating to a hold rating in a report on Wednesday, May 3rd. Wedbush increased their price target on Intersect ENT from $25.00 to $26.00 and gave the stock an outperform rating in a report on Wednesday, May 3rd. Finally, Deutsche Bank AG upgraded Intersect ENT from a hold rating to a buy rating and increased their price target for the stock from $15.00 to $19.00 in a report on Monday, March 6th. Five analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The company has an average rating of Buy and a consensus price target of $18.60.

Northland Securities cut shares of Intersect ENT Inc (NASDAQ:XENT) from an outperform rating to a market perform rating in a research report report published on Wednesday morning.

Intersect ENT (NASDAQ:XENT) last posted its quarterly earnings results on Tuesday, May 2nd. The medical equipment provider reported ($0.23) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.25) by $0.02. The firm had revenue of $20.47 million for the quarter, compared to analysts’ expectations of $19.39 million. Intersect ENT had a negative return on equity of 23.87% and a negative net margin of 32.63%. Equities research analysts predict that Intersect ENT will post ($0.74) earnings per share for the current year. In other news, insider Lisa D. Earnhardt sold 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, March 15th. The stock was sold at an average price of $15.02, for a total transaction of $300,400.00. Following the transaction, the insider now directly owns 620,868 shares of the company’s stock, valued at $9,325,437.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders have sold 81,250 shares of company stock worth $1,560,163 over the last ninety days. 13.90% of the stock is owned by insiders.

Several institutional investors have recently modified their holdings of the company. Paulson & CO. Inc. purchased a new position in shares of Intersect ENT during the first quarter worth $10,978,000. FMR LLC raised its position in shares of Intersect ENT by 255.4% in the first quarter. FMR LLC now owns 426,520 shares of the medical equipment provider’s stock worth $7,315,000 after buying an additional 306,520 shares during the last quarter. Marshall Wace LLP purchased a new position in shares of Intersect ENT during the first quarter worth $5,129,000. Neuberger Berman Group LLC raised its position in shares of Intersect ENT by 49.8% in the first quarter. Neuberger Berman Group LLC now owns 884,627 shares of the medical equipment provider’s stock worth $15,171,000 after buying an additional 293,949 shares during the last quarter. Finally, Kopp Investment Advisors LLC raised its position in shares of Intersect ENT by 49.9% in the fourth quarter. Kopp Investment Advisors LLC now owns 357,795 shares of the medical equipment provider’s stock worth $4,329,000 after buying an additional 119,097 shares during the last quarter. 77.81% of the stock is currently owned by institutional investors. About Intersect ENT

Intersect ENT, Inc is a commercial-stage drug-device company. The Company develops drugs for patients with ear, nose and throat (ENT) conditions. The Company has developed a drug releasing bioabsorbable implant technology that enables targeted and sustained release of therapeutic agents. This targeted drug delivery technology is designed to allow ENT physicians to manage patient care.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NASDAQ:XENT”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Related posts

Leave a Comment